Brief: Coya Therapeutics Provides A Corporate Update And Reports Fiscal 2025 Financial Results
16/03/2026 12:10
March 16 (Reuters) - Coya Therapeutics Inc COYA.O: COYA THERAPEUTICS PROVIDES A CORPORATE UPDATE AND REPORTS FISCAL 2025 FINANCIAL RESULTS Source text: ID:nBwb891fWa Further company coverage: COYA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Coya Therapeutics
See all newsCoya Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Coya Therapeutics Q2 net loss widens as R&D costs rise
Coya Therapeutics Inc expected to post a loss of 34 cents a share - Earnings Preview
Brief: Coya Therapeutics Entered Into Sales Agreement, May Offer And Sell From Time To Time Shares Of Co's Common Stock For Up To $30 Million
Brief: Coya Therapeutics Has Been Granted U.S. FDA Fast Track Designation For Coya 302 For The Treatment Of Amyotrophic Lateral Sclerosis (ALS)